Physician profile
Lloyd Clifton Stringer
NPI 1386206068
$1,415.47
in general payments reported to CMS, 2019-2025
17 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $192 · 2022: $325 · 2023: $271 · 2024: $310 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $262.70 | 2022-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $247.37 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $218.16 | 2022-2025 | Trintellix |
| Pfizer INC. | $145.45 | 2024-2025 | |
| Lilly USA, LLC | $108.60 | 2022-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.90 | 2024-2025 | Jardiance |
| Endo Pharmaceuticals INC. | $69.11 | 2021-2023 | Nascobal |
| Astrazeneca Pharmaceuticals LP | $67.94 | 2021-2025 | Breztri, Airsupra |
| Eisai INC. | $45.56 | 2021 | |
| Janssen Pharmaceuticals, INC | $36.67 | 2021 | |
| Axsome Therapeutics, INC. | $32.08 | 2023 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $24.60 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.85 | 2025 | Xifaxan |
| Ibsa Pharma INC. | $20.39 | 2022 | |
| Indivior INC. | $13.11 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.01 | 2023 | |
| Lundbeck LLC | $12.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lloyd Stringer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.